.. ople and would allow states to determine for themselves whether marijuana should be legal for medicinal use. It is a common-sense solution to a complex issue and would provide a great deal of relief from suffering for a large number of people.
NORML implores Congress to support this compassionate proposal to protect the ten of thousands of Americans who currently use marijuana as a medicine and the millions who would benefit from its legal access. Many seriously ill patients find marijuana the most effective way to relieve their pain and suffering and federal marijuana prohibition must not, in good conscience, continue to deny them that medication. Bibliography 1. House of Lords Select Committee on Science and Technology, Ninth Report, London: United Kingdom (1998); American Public Health Association, Resolution 9513: Access to Therapeutic Marijuana/Cannabis, Washington, DC: APHA Public Policy Statements (1995); Commonwealth Department of Human Services and Health, The health and psychological consequences of cannabis use, Canberra, Australia: Australian Government Publishing Service (1994): 185-199; Federation of American Scientists, Medical Use of Whole Cannabis, Washington, DC: Statement of the FAS (1994); Lester Grinspoon, M.D. et al., Marihuana, The Forbidden Medicine (second edition), New Haven, Connecticut: Yale University Press (1997); John Morgan, M.D.
et al., Marijuana Myths, Marijuana Facts: A Review of the Scientific Evidence, New York City: Lindesmith Center (1997): 17-25. 2. Institute of Medicine News, March 17, 1999; National Academy of Sciences Institute of Medicine, Marijuana and Medicine: Assessing the Science Base, Washington, DC: National Academy Press (1999); http://www.norml.org/medical/IOM Report/iomlv.htm. 3. Lester Grinspoon, M.D., et al., Marihuana, The Forbidden Medicine. 4.
R.C. Randall, Cancer Treatment & Marijuana Therapy, Washington, DC: Galen Press (1990): 217-243; Kevin Zeese, Marijuana: Medical Effectiveness Is Proven By Research, Falls Church, Virginia: Common Sense for Drug Policy (1997); Annual Report: Evaluation of Marijuana and Tetrahydrocannabinol in Treatment of Nausea and/or Vomiting Associated with Cancer Therapy Unresponsive to Conventional Anti-Emetic Therapy: Efficacy and Toxicity, Board of Pharmacy, State of Tennessee, (1983); McNeil, Robert P., The Lynn Pierson Therapeutic Research Program: A Report on Progress to Date, Behavioral Health Services Division, Health and Environment Department, State of New Mexico, (1983); Seventeenth Annual Report of the Research Advisory Panel, prepared for the Governor and Legislature by the California Research Advisory Panel, San Francisco, California, (1986); Michigan Department of Public Health Marijuana Therapeutic Research Project, Trial A 1980-81, Department of Social Oncology, Evaluation Unit. Michigan Cancer Foundation, (1982), Kunter, Michael H., Evaluation of the Use of Both Marijuana and THC in Cancer Patients for the Relief of Nausea and Vomiting Associated with Cancer Chemotherapy After Failure of Conventional Anti-Emetic Therapy: Efficacy and Toxicity, as prepared for the Composite State Board of Medical Examiners, Georgia Department of Health, Emory University, Atlanta, Georgia (1983); Annual Report to the Governor and Legislature on the Antonio G. Olivieri Controlled Substances Therapeutic Research Program, New York State Department of Health, (1986) as it appeared in Cancer Treatment and Marijuana Therapy, (1990). 5.
Annual Report: Evaluation of Marijuana and Tetrahydrocannabinol in Treatment of Nausea and/or Vomiting Associated with Cancer Therapy Unresponsive to Conventional Anti-Emetic Therapy: Efficacy and Toxicity, Board of Pharmacy, State of Tennessee; The Lynn Pierson Therapeutic Research Program: A Report on Progress to Date, Behavioral Health Services Division, Health and Environment Department, State of New Mexico; Seventeenth Annual Report of the Research Advisory Panel, prepared for the Governor and Legislature by the California Research Advisory Panel; Vincent Vinciguerra, et al., Inhalation marijuana as an antiemetic for cancer chemotherapy, New York State Journal of Medicine, (1988): 525-527. 6. Institute of Medicine News, March 17, 1999. 7.
Rick Doblin, et al., Marihuana as Anti-emetic Medicine: A Survey of Oncologists’ Attitudes and Experiences, Journal of Clinical Oncology, (1991): 1275-80; John Morgan, M.D. et al., Marijuana Myths, Marijuana Facts: A Review of the Scientific Evidence, 20. 8. Commonwealth Department of Human Services and Health, The health and psychological consequences of cannabis use, 195; Richard Kaslow, M.D., et al., No Evidence for a Role of Alcohol or Other Psychoactive Drugs in Accelerating Immunodeficiency in HIV-1 Positive Individuals, Journal of The American Medical Association, (1989): 3424-29.
9. National Institues of Health, Workshop on the Medical Utility of Marijuana, Report to the Director, Washington, D.C. (1997): 4. 10. National Academy of Sciences Institute of Medicine, Marijuana as Medicine: Assessing the Science Base, 4.22. 11.
Institute of Medicine News, March 17, 1999. National Academy of Sciences Institute of Medicine, Marijuana and Health, Washington, DC: National Academy Press (1982): 140-151. 12. National Academy of Sciences Institute of Medicine, Marijuana and Health, Washington, DC: National Academy Press (1982): 140-151.
13. Commonwealth Department of Human Services and Health, The health and psychological consequences of cannabis use, 199. 14. House of Lords Select Committee on Science and Technology, Ninth Report; Associated Press, November 12, 1998.
15. Institute of Medicine News, March 17, 1999. 16. National Academy of Sciences Institute of Medicine, Marijuana and Medicine: Assessing the Science Base, 4.9. 17. Synthetic marijuana-like drug eases pain – study, Reuters News Service, September 23, 1998; Study Explains How Marijuana Kills Pain, San Francisco Chronicle, September 24, 1998; Easing the Agony: Marijuana does more than merely make you stoned, The New Scientist (United Kingdom), September 26, 1998; Cannabinoid Anagesia Explained, The Lancet, September 26, 1998; How Does Marijuana Kill Pain, Associated Press, October 4, 1998.
18. Society for Neuroscience, Press Conference: Marijuana & Analgesia, October 26, 1997. 19. A. Hampson, et al., Cannabidiol and delta-9-tetrahydrocannabinol are neuroprotective antioxidants, Proceedings of the National Academy of Sciences 95 (1998): 8268-8273; Cannabis is stroke hope, The Guardian (United Kingdom), July 4, 1998; Marijuanas Healing Properties, Associated Press, July 5, 1998. 20.
Ibid. 21. Alabama, Alaska, Arkansas, Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Iowa, Illinois, Louisiana, Maine, Massachusetts, Michigan, Minnesota, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oregon, Rhode Island, South Carolina, Tennessee, Texas, Virginia, Vermont, Washington, Wisconsin, West Virginia. 22. Alabama (S. 559); Connecticut (H.B.
5217); District of Columbia (Bill No. 4-123); Georgia (H.B. 1077); Iowa (S.F. 487); Illinois (H.B. 2625); Louisiana (H.B. 1187); Massachusetts (H.
2170); Minnesota (H.F. 2476); Montana (H.B. 463); New Hampshire (S.B. 21); New Jersey (A.B.
819); New Mexico (H.B. 329); New York (S.B. 1123-6); Rhode Island (H.B. 79.6072); South Carolina (S.B. 350); Tennessee (H.B.
314); Texas (S.B. 877); Vermont (H.B. 130); Virginia (S.B. 913); Washington (S.B.
6744); West Virginia (S.B. 366); Wisconsin (A.B. 697); http://www.norml.org/medical/states.shtml. 23. http://www.norml.org/medical/pets98.shtml. 24.
http://www.norml.org/medical/polls.shtml. 25. Americans Oppose General Legalization of Marijuana, but Support Use for Medicinal Purposes, Gallup Poll News Service, Volume 63, No. 44, March 26, 1999.
26. In the Matter of Marihuana Rescheduling Petition, Docket 86-22, Opinion, Recommended Ruling, Findings of fact, Conclusions of Law, and Decision of Administrative Law Judge, September 6, 1988 (Washington, DC: Drug Enforcement Administration, 1988). 27. Ibid. 28. http://www.norml.org/laws/HR912.html.
Legal Issues.
